EFNB2 and Hyperglycemia: Hyperglycaemia-activated miR-503 is packaged into endothelial EVs and delivered to vascular pericytes, resulting in reduced expression of Ephrin-B2 (EFNB2) and vascular endothelial growth factor (VEGF) in these cells, followed by impaired migration and proliferation21.